Patents by Inventor Brian Kwan

Brian Kwan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250220050
    Abstract: In an embodiment, a method includes receiving, via a processor, identity provider (IDP)/single sign on (SSO) data that is associated with an IDP and an SSO entity. The IDP and the SSO entity manage access to a plurality of cloud-based applications for a plurality of user compute devices for a plurality of users. The method further includes generating, via the processor and without accessing the plurality of cloud-based applications, analytics based on the IDP/SSO data. The method further includes causing, via the processor, an action based on the analytics.
    Type: Application
    Filed: March 17, 2025
    Publication date: July 3, 2025
    Inventors: Alexander VANDENBERG-RODES, Steven LITVACK-WINKLER, Brian Kwan Fong LAU, Neha DUGGAL, Naresh CHEBOLU, Simon LUTTERBIE, David Samuel ELSTON
  • Patent number: 12278846
    Abstract: In an embodiment, a method includes receiving, via a processor, identity provider (IDP)/single sign on (SSO) data that is associated with an IDP and an SSO entity. The IDP and the SSO entity manage access to a plurality of cloud-based applications for a plurality of user compute devices for a plurality of users. The method further includes generating, via the processor and without accessing the plurality of cloud-based applications, analytics based on the IDP/SSO data. The method further includes causing, via the processor, an action based on the analytics.
    Type: Grant
    Filed: June 24, 2024
    Date of Patent: April 15, 2025
    Assignee: Obsidian Security, Inc.
    Inventors: Alexander Vandenberg-Rodes, Steven Litvack-Winkler, Brian Kwan Fong Lau, Neha Duggal, Naresh Chebolu, Simon Lutterbie, David Samuel Elston
  • Publication number: 20250118445
    Abstract: Systems and methods are disclosed to optimize resources of a medical device system, including to analyze physiologic information of a patient occurring over specific time periods relative to a prior heart failure event, to adjust, in response to a detected or received trigger event, a baseline value for the patient from a long-term baseline value to one of a shorter-term baseline value or a static value indicative of a baseline value at a prior time relative to the detected or received trigger event, to determine a readmission score for the patient based on the analyzed physiologic information, and to provide a control signal to control a mode or operation of the medical device system based on the readmission score to optimize resources of the medical device system.
    Type: Application
    Filed: October 2, 2024
    Publication date: April 10, 2025
    Inventors: Jonathan Bennett Shute, Ramesh Wariar, Stephen B. Ruble, Sean Thomas Horan, Brian Kwan, Craig Stolen
  • Publication number: 20240430307
    Abstract: In an embodiment, a method includes receiving, via a processor, identity provider (IDP)/single sign on (SSO) data that is associated with an IDP and an SSO entity. The IDP and the SSO entity manage access to a plurality of cloud-based applications for a plurality of user compute devices for a plurality of users. The method further includes generating, via the processor and without accessing the plurality of cloud-based applications, analytics based on the IDP/SSO data. The method further includes causing, via the processor, an action based on the analytics.
    Type: Application
    Filed: June 24, 2024
    Publication date: December 26, 2024
    Inventors: Alexander VANDENBERG-RODES, Steven LITVACK-WINKLER, Brian Kwan Fong LAU, Neha DUGGAL, Naresh CHEBOLU, Simon LUTTERBIE, David Samuel ELSTON
  • Publication number: 20230301601
    Abstract: Systems and methods to predict a patient mortality risk are disclosed, including determining a risk value for a plurality of physiologic measures and determining a mortality risk metric indicative of a risk of patient mortality as a weighted combination of the plurality of physiologic measures having risk values satisfying a pre-determined condition.
    Type: Application
    Filed: March 23, 2023
    Publication date: September 28, 2023
    Inventors: Viktoria A. Averina, Ramesh Wariar, Pramodsingh Hirasingh Thakur, Brian Kwan, Stephen B. Ruble
  • Patent number: 11600305
    Abstract: Systems and methods are provided for reordering and/or bypassing certain informational content or menus that are conventionally presented prior to playback of media content stored on physical media discs. Upon initial use of a physical media disc, certain information content or menus may be presented to a user or viewer, for example, piracy warnings, language selection menus, etc. However, upon subsequent use of the physical media disc, such informational content or menus may be bypassed. The user or viewer is given an option to immediately begin consuming the media content stored on the physical media disc. Conventional content, such as trailers are not played prior to playback of the media content.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: March 7, 2023
    Assignee: Disney Enterprises, Inc.
    Inventors: Brian Kwan, David M. Jessen, James J. Madden
  • Patent number: 11582507
    Abstract: Methods and apparatuses are provided, which may be implemented to combine and distribute user enhanced video and/or audio content.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: February 14, 2023
    Assignee: Disney Enterprises, Inc.
    Inventors: Kyle Prestenback, Evan Tahler, Brian Kwan, David Jessen
  • Publication number: 20200312377
    Abstract: Systems and methods are provided for reordering and/or bypassing certain informational content or menus that are conventionally presented prior to playback of media content stored on physical media discs. Upon initial use of a physical media disc, certain information content or menus may be presented to a user or viewer, for example, piracy warnings, language selection menus, etc. However, upon subsequent use of the physical media disc, such informational content or menus may be bypassed. The user or viewer is given an option to immediately begin consuming the media content stored on the physical media disc. Conventional content, such as trailers are not played prior to playback of the media content.
    Type: Application
    Filed: June 12, 2020
    Publication date: October 1, 2020
    Inventors: Brian KWAN, David M. JESSEN, James J. MADDEN
  • Patent number: 10741221
    Abstract: Systems and methods are provided for reordering and/or bypassing certain informational content or menus that are conventionally presented prior to playback of media content stored on physical media discs. Upon initial use of a physical media disc, certain information content or menus may be presented to a user or viewer, for example, piracy warnings, language selection menus, etc. However, upon subsequent use of the physical media disc, such informational content or menus may be bypassed. The user or viewer is given an option to immediately begin consuming the media content stored on the physical media disc. Conventional content, such as trailers are not played prior to playback of the media content.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: August 11, 2020
    Assignee: Disney Enterprises, Inc.
    Inventors: Brian Kwan, David M. Jessen, James J. Madden
  • Patent number: 10587833
    Abstract: Embodiments disclosed herein include systems and methods which allow consumers of audio-visual content (such as movies and television programs) to obtain dynamic additional content about programs and movies being watched, and customize that additional content to their personal preferences and behaviors.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: March 10, 2020
    Assignee: Disney Enterprises, Inc.
    Inventors: Todd Allen Mendeloff, William Joseph Bartley, Brian Kwan, David Jessen, Evan Acosta
  • Publication number: 20190313148
    Abstract: Methods and apparatuses are provided, which may be implemented to combine and distribute user enhanced video and/or audio content.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 10, 2019
    Inventors: Kyle Prestenback, Evan Tahler, Brian Kwan, David Jessen
  • Patent number: 10238689
    Abstract: The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are difficult to treat due to persister cells, a subpopulation of all bacterial populations that is highly tolerant against all traditional antibiotics since the cells are dormant and antibiotics are designed to kill growing cells. Here, we show that MMC and cisplatin eradicate persister cells through a growth-independent mechanism, cross-linking DNA. We find both agents are effective against both planktonic cultures and highly robust biofilm cultures for a broad range of bacterial species, including commensal Escherichia coli K-12 as well as pathogenic species of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. In certain approaches cisplatin is superior to MMC.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: March 26, 2019
    Assignee: The Penn State Research Foundation
    Inventors: Thomas Wood, Brian Kwan, Nityananda Chowdhury
  • Publication number: 20190019536
    Abstract: Systems and methods are provided for reordering and/or bypassing certain informational content or menus that are conventionally presented prior to playback of media content stored on physical media discs. Upon initial use of a physical media disc, certain information content or menus may be presented to a user or viewer, for example, piracy warnings, language selection menus, etc. However, upon subsequent use of the physical media disc, such informational content or menus may be bypassed. The user or viewer is given an option to immediately begin consuming the media content stored on the physical media disc. Conventional content, such as trailers are not played prior to playback of the media content.
    Type: Application
    Filed: December 1, 2017
    Publication date: January 17, 2019
    Applicant: DISNEY ENTERPRISES, INC.
    Inventors: BRIAN KWAN, DAVID M. JESSEN, JAMES J. MADDEN
  • Publication number: 20180117083
    Abstract: The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are difficult to treat due to persister cells, a subpopulation of all bacterial populations that is highly tolerant against all traditional antibiotics since the cells are dormant and antibiotics are designed to kill growing cells. Here, we show that MMC and cisplatin eradicate persister cells through a growth-independent mechanism, cross-linking DNA. We find both agents are effective against both planktonic cultures and highly robust biofilm cultures for a broad range of bacterial species, including commensal Escherichia coli K-12 as well as pathogenic species of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. In certain approaches cisplatin is superior to MMC.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 3, 2018
    Inventors: Thomas Wood, Brian Kwan, Nityananda Chowdhury
  • Patent number: 9959897
    Abstract: User inputs are received from one or more of a plurality of sources at an input interpreter agent. The plurality of sources comprises a remote control device and an on-screen keyboard application. The received user inputs are provided to a digital video object player application, wherein the input interpreter agent is separate from the digital video object player application.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: May 1, 2018
    Assignee: Disney Enterprises, Inc.
    Inventors: Kyle Prestenback, Evan Tahler, David Jessen, Brian Kwan
  • Patent number: 9801909
    Abstract: The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are difficult to treat due to persister cells, a subpopulation of all bacterial populations that is highly tolerant against all traditional antibiotics since the cells are dormant and antibiotics are designed to kill growing cells. Here, we show that MMC and cisplatin eradicate persister cells through a growth-independent mechanism, cross-linking DNA. We find both agents are effective against both planktonic cultures and highly robust biofilm cultures for a broad range of bacterial species, including commensal Escherichia coli K-12 as well as pathogenic species of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. In certain approaches cisplatin is superior to MMC.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: October 31, 2017
    Assignee: The Penn State Research Foundation
    Inventors: Thomas Wood, Brian Kwan, Nityananda Chowdhury
  • Patent number: 9639850
    Abstract: Systems and associated methods for incentivizing content engagement are described. Embodiments provide a recommended feature application to offer premier/recommended content. This can take place at a variety of times, for example during the primary content selection interface display, as well as offering said content interactively as an overlay during the conclusion of a piece of content. Embodiments employ a weighted process for selecting a recommended feature based on one or more stored preference files. The recommended feature application can be utilized across titles.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: May 2, 2017
    Assignee: Disney Enterprises, Inc.
    Inventors: Jeffrey R. Ashbrook, Kyle Prestenback, Evan Acosta, Brian Kwan, David Jessen
  • Publication number: 20160287630
    Abstract: The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are difficult to treat due to persister cells, a subpopulation of all bacterial populations that is highly tolerant against all traditional antibiotics since the cells are dormant and antibiotics are designed to kill growing cells. Here, we show that MMC and cisplatin eradicate persister cells through a growth-independent mechanism, cross-linking DNA. We find both agents are effective against both planktonic cultures and highly robust biofilm cultures for a broad range of bacterial species, including commensal Escherichia coli K-12 as well as pathogenic species of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. In certain approaches cisplatin is superior to MMC.
    Type: Application
    Filed: April 1, 2016
    Publication date: October 6, 2016
    Inventors: Thomas Wood, Brian Kwan, Nityananda Chowdhury
  • Patent number: 9183558
    Abstract: Systems and methods disclosed herein include systems and methods for delivering secondary content to a plurality of portable devices, the secondary content comprising events synchronized to primary content, the process including delivering an application to a plurality of portable display devices, the application configured to execute events on the portable display devices; and causing the events executed on the portable display devices to be synchronized with primary content.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: November 10, 2015
    Assignee: DISNEY ENTERPRISES, INC.
    Inventors: James K. Davy, Brian Kwan, David M. Jessen, James Madden
  • Patent number: 9055269
    Abstract: Subject matter disclosed herein may relate to messaging techniques with user generated content related to video object timecode.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: June 9, 2015
    Assignee: Disney Enterprises, Inc.
    Inventors: Kyle Prestenback, Evan Tahler, Brian Kwan, Allison Crow, Aaron Daly